obesity drug news today glp-1 today Today: Medicare Update Weight loss with GLP-1 medicines
Description
Science 359, 11511156
Buyers who want to evaluate supplement options while that equation is still favorable are better positioned to do that now than after the prescription landscape reshapes the category further
Comparator groups and exposure definitions also varied across studies, and prescription records did not always confirm that the medications were taken
Rossing P, Baeres FMM, Bakris G et al (2023) The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Exercise Prescription
